Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effectiveness of XBB.1.5 Monovalent COVID-19 Vaccines During a Period of XBB.1.5 Dominance in EU/EEA Countries, October to November 2023: A VEBIS-EHR Network Study.
Monge S, Humphreys J, Nicolay N, Braeye T, Van Evercooren I, Holm Hansen C, Emborg HD, Sacco C, Mateo-Urdiales A, Castilla J, Martínez-Baz I, de Gier B, Hahné S, Meijerink H, Kristoffersen AB, Machado A, Soares P, Nardone A, Bacci S, Kissling E, Nunes B; VEBIS‐EHR Working Group. Monge S, et al. Among authors: mateo urdiales a. Influenza Other Respir Viruses. 2024 Apr;18(4):e13292. doi: 10.1111/irv.13292. Influenza Other Respir Viruses. 2024. PMID: 38654485 Free PMC article.
Effect of an enhanced public health contact tracing intervention on the secondary transmission of SARS-CoV-2 in educational settings: The four-way decomposition analysis.
Djuric O, Larosa E, Cassinadri M, Cilloni S, Bisaccia E, Pepe D, Bonvicini L, Vicentini M, Venturelli F, Giorgi Rossi P, Pezzotti P, Mateo Urdiales A, Bedeschi E; Reggio Emilia Covid-19 Working Group. Djuric O, et al. Among authors: mateo urdiales a. Elife. 2024 Feb 28;13:e85802. doi: 10.7554/eLife.85802. Elife. 2024. PMID: 38416129 Free PMC article.
Excess Mortality During 2020 in Spain: The Most Affected Population, Age, and Educational Group by the COVID-19 Pandemic.
Pulido J, Barrio G, Donat M, Politi J, Moreno A, Cea-Soriano L, Guerras JM, Huertas L, Mateo-Urdiales A, Ronda E, Martínez D, Lostao L, Belza MJ, Regidor E. Pulido J, et al. Among authors: mateo urdiales a. Disaster Med Public Health Prep. 2024 Feb 19;18:e27. doi: 10.1017/dmp.2024.17. Disaster Med Public Health Prep. 2024. PMID: 38372080
Relative vaccine effectiveness against COVID-19 hospitalisation in persons aged ≥ 65 years: results from a VEBIS network, Europe, October 2021 to July 2023.
Fontán-Vela M, Kissling E, Nicolay N, Braeye T, Van Evercooren I, Holm Hansen C, Emborg HD, Fabiani M, Mateo-Urdiales A, AlKerwi A, Schmitz S, Castilla J, Martínez-Baz I, de Gier B, Hahné S, Meijerink H, Starrfelt J, Nunes B, Caetano C, Derrough T, Nardone A, Monge S; VEBIS-Lot4 working group; VEBIS-Lot 4 working group. Fontán-Vela M, et al. Among authors: mateo urdiales a. Euro Surveill. 2024 Jan;29(1):2300670. doi: 10.2807/1560-7917.ES.2024.29.1.2300670. Euro Surveill. 2024. PMID: 38179626 Free PMC article.
A comparison of COVID-19 incidence rates across six European countries in 2021.
Padget M, Adam P, Dorfmuller M, Blondel C, Campos-Matos I, Fayad M, Mateo-Urdiales A, Mesher D, Pistol A, Rebolledo J, Riccardo F, Riess M, Rusu LC, Che D, Coignard B; COVID-19 Study group; COVID-19 Study Group members. Padget M, et al. Among authors: mateo urdiales a. Euro Surveill. 2023 Oct;28(40):2300088. doi: 10.2807/1560-7917.ES.2023.28.40.2300088. Euro Surveill. 2023. PMID: 37796443 Free PMC article.
Estimated Effectiveness of a Primary Cycle of Protein Recombinant Vaccine NVX-CoV2373 Against COVID-19.
Mateo-Urdiales A, Sacco C, Petrone D, Bella A, Riccardo F, Del Manso M, Bressi M, Siddu A, Brusaferro S, Palamara AT, Rezza G, Pezzotti P, Fabiani M; Italian National COVID-19 Integrated Surveillance System and the Italian COVID-19 vaccines registry. Mateo-Urdiales A, et al. JAMA Netw Open. 2023 Oct 2;6(10):e2336854. doi: 10.1001/jamanetworkopen.2023.36854. JAMA Netw Open. 2023. PMID: 37792377 Free PMC article.
Estimating SARS-CoV-2 infections and associated changes in COVID-19 severity and fatality.
Marziano V, Guzzetta G, Menegale F, Sacco C, Petrone D, Mateo Urdiales A, Del Manso M, Bella A, Fabiani M, Vescio MF, Riccardo F, Poletti P, Manica M, Zardini A, d'Andrea V, Trentini F, Stefanelli P, Rezza G, Palamara AT, Brusaferro S, Ajelli M, Pezzotti P, Merler S. Marziano V, et al. Among authors: mateo urdiales a. Influenza Other Respir Viruses. 2023 Aug 16;17(8):e13181. doi: 10.1111/irv.13181. eCollection 2023 Aug. Influenza Other Respir Viruses. 2023. PMID: 37599801 Free PMC article.
Relative effectiveness of bivalent Original/Omicron BA.4-5 mRNA vaccine in preventing severe COVID-19 in persons 60 years and above during SARS-CoV-2 Omicron XBB.1.5 and other XBB sublineages circulation, Italy, April to June 2023.
Fabiani M, Mateo-Urdiales A, Sacco C, Rota MC, Fotakis EA, Petrone D, Del Manso M, Siddu A, Stefanelli P, Bella A, Riccardo F, Rezza G, Palamara AT, Brusaferro S, Pezzotti P; Italian Integrated Surveillance of COVID-19 study group and of the Italian COVID-19 Vaccines Registry group. Fabiani M, et al. Among authors: mateo urdiales a. Euro Surveill. 2023 Aug;28(32):2300397. doi: 10.2807/1560-7917.ES.2023.28.32.2300397. Euro Surveill. 2023. PMID: 37561053 Free PMC article.
Relative effectiveness of monovalent and bivalent mRNA boosters in preventing severe COVID-19 due to omicron BA.5 infection up to 4 months post-administration in people aged 60 years or older in Italy: a retrospective matched cohort study.
Mateo-Urdiales A, Sacco C, Fotakis EA, Del Manso M, Bella A, Riccardo F, Bressi M, Rota MC, Petrone D, Siddu A, Fedele G, Stefanelli P, Palamara AT, Brusaferro S, Rezza G, Pezzotti P, Fabiani M. Mateo-Urdiales A, et al. Lancet Infect Dis. 2023 Dec;23(12):1349-1359. doi: 10.1016/S1473-3099(23)00374-2. Epub 2023 Jul 18. Lancet Infect Dis. 2023. PMID: 37478877
38 results